Case-control study reveals higher psychiatric comorbidities and smoking rates in COPD patients, indicating significant health impacts.
Background: Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a condition with multisystem involvement, including psychiatric comorbidities. Tobacco smoking, a primary etiological factor for COPD, may also predispose individuals to psychological distress. Aims and Objectives: To assess the prevalence and pattern of psychiatric comorbidities in COPD patients, evaluate smoking history, and analyze their associations with COPD severity. Materials and Methods: A case–control study was conducted involving 221 COPD patients and 221 age-and gender-matched controls. Demographic profiles, smoking history (including pack-years), and psychiatric assessments were recorded. Psychiatric diagnoses were established using standard clinical interviews based on international classification of diseases, 10th edition criteria. Statistical analysis was performed using Chi-square tests to determine associations, with significance set at P<0.05. Results: Cases exhibited significantly higher rates of smoking, with regular smokers constituting 51.1% compared to 14.0% of controls (P=0.0001). Psychiatric comorbidities were substantially elevated in cases, notably dysthymia (35.29% vs. 17.65%; P=0.0002), generalized anxiety disorder (41.63% vs. 21.72%; P=0.0001), and recurrent depressive disorder (29.86% vs. 13.57%; P=0.0001). Higher COPD severity grades were associated with increased psychiatric morbidity (P<0.05). Conclusion: COPD is strongly associated with a higher burden of psychiatric comorbidities and tobacco exposure. Integrating psychiatric evaluation into COPD management could enhance holistic patient care.
No takes yet. Share an insight, caveat, or question.
Pathak et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: